This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 May 18;11(6):442.

doi: 10.1038/nrd3759.

Bone diseases: SEMA3A strikes a balance in bone homeostasis

PMID: 22596250
DOI: 10.1038/nrd3759

Comment

Bone diseases: SEMA3A strikes a balance in bone homeostasis

Man Tsuey Tse. Nat Rev Drug Discov. 2012.

. 2012 May 18;11(6):442.

doi: 10.1038/nrd3759.

Author

PMID: 22596250
DOI: 10.1038/nrd3759

No abstract available

PubMed Disclaimer

Comment on

Osteoprotection by semaphorin 3A.
Hayashi M, Nakashima T, Taniguchi M, Kodama T, Kumanogoh A, Takayanagi H. Hayashi M, et al. Nature. 2012 May 3;485(7396):69-74. doi: 10.1038/nature11000. Nature. 2012. PMID: 22522930

Similar articles

Autoregulation of Osteocyte Sema3A Orchestrates Estrogen Action and Counteracts Bone Aging.
Hayashi M, Nakashima T, Yoshimura N, Okamoto K, Tanaka S, Takayanagi H. Hayashi M, et al. Cell Metab. 2019 Mar 5;29(3):627-637.e5. doi: 10.1016/j.cmet.2018.12.021. Epub 2019 Jan 17. Cell Metab. 2019. PMID: 30661929
Adenosine A_2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis.
Mediero A, Wilder T, Shah L, Cronstein BN. Mediero A, et al. FASEB J. 2018 Jul;32(7):3487-3501. doi: 10.1096/fj.201700217R. Epub 2018 Feb 2. FASEB J. 2018. PMID: 29394106 Free PMC article.
Wedelolactone Enhances Osteoblastogenesis but Inhibits Osteoclastogenesis through Sema3A/NRP1/PlexinA1 Pathway.
Liu YQ, Han XF, Bo JX, Ma HP. Liu YQ, et al. Front Pharmacol. 2016 Oct 18;7:375. doi: 10.3389/fphar.2016.00375. eCollection 2016. Front Pharmacol. 2016. PMID: 27803667 Free PMC article.
Emerging role of semaphorin-3A in autoimmune diseases.
Liu LN, Li XM, Ye DQ, Pan HF. Liu LN, et al. Inflammopharmacology. 2018 Jun;26(3):655-665. doi: 10.1007/s10787-018-0484-y. Epub 2018 Apr 25. Inflammopharmacology. 2018. PMID: 29696565 Review.
Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus.
Vadasz Z, Toubi E. Vadasz Z, et al. Lupus. 2012 Oct;21(12):1266-70. doi: 10.1177/0961203312456753. Epub 2012 Aug 8. Lupus. 2012. PMID: 22875653 Review.

See all similar articles

Cited by

Pathogenic mechanisms of glucocorticoid-induced osteoporosis.
Chen M, Fu W, Xu H, Liu CJ. Chen M, et al. Cytokine Growth Factor Rev. 2023 Apr;70:54-66. doi: 10.1016/j.cytogfr.2023.03.002. Epub 2023 Mar 5. Cytokine Growth Factor Rev. 2023. PMID: 36906448 Free PMC article. Review.
LncRNA TCF7 contributes to high glucose-induced damage in human podocytes by up-regulating SEMA3A via sponging miR-16-5p.
Jiang Z, Qian L, Yang R, Wu Y, Guo Y, Chen T. Jiang Z, et al. J Diabetes Investig. 2023 Feb;14(2):193-204. doi: 10.1111/jdi.13904. Epub 2022 Dec 29. J Diabetes Investig. 2023. PMID: 36583231 Free PMC article.
The effects of semaphorin 3A in bone and cartilage metabolism: fundamental mechanism and clinical potential.
Wu K, Huang D, Huang X. Wu K, et al. Front Cell Dev Biol. 2023 Nov 23;11:1321151. doi: 10.3389/fcell.2023.1321151. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38078001 Free PMC article. Review.
Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload-Induced Heart Disease.
Li C, Zhao Y, Li F, Wang Z, Qiu Z, Yang Y, Xiong W, Wang R, Chen H, Xu F, Zang T, Pei Z, Wang Y, Shi B, Shen L, Ge J. Li C, et al. Adv Sci (Weinh). 2023 Jul;10(21):e2206801. doi: 10.1002/advs.202206801. Epub 2023 Jun 13. Adv Sci (Weinh). 2023. PMID: 37310417 Free PMC article.
Periostin: An Emerging Molecule With a Potential Role in Spinal Degenerative Diseases.
Zhu D, Zhou W, Wang Z, Wang Y, Liu M, Zhang G, Guo X, Kang X. Zhu D, et al. Front Med (Lausanne). 2021 Aug 27;8:694800. doi: 10.3389/fmed.2021.694800. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34513869 Free PMC article. Review.

See all "Cited by" articles

References

1. Nat Rev Drug Discov. 2011 Feb;10(2):141-56 - PubMed
1. Nature. 2012 May 3;485(7396):69-74 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group